Company / Operating Cash Flow
Sanara MedTech Inc. Operating Cash Flow History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$23.8K
FY2025
5-year range
-$5.6M / -$23.8K
FY2021-FY2025
Trend
+99.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$6M to -$23,784 over the past 2 years.
Based on SEC 10-K filings.
-$23,784 in FY2025.
Improved from -$6M to -$23,784 over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow increased 99.3% year-over-year.
- Peak operating cash flow was recorded in FY2017.
- Lowest operating cash flow in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$23.8K | +99.3% |
| FY2024 | -$3.2M | +41.6% |
| FY2023 | -$5.6M | -15.4% |
| FY2022 | -$4.8M | -19.3% |
| FY2021 | -$4.0M | -86.1% |
| FY2020 | -$2.2M | -1449.7% |
| FY2018 | -$139.9K | -134.2% |
| FY2017 | $409.2K | +134.0% |
| FY2016 | -$1.2M | +28.7% |
| FY2015 | -$1.7M | +7.4% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026